Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells
- PMID: 15561377
- DOI: 10.1016/j.pain.2004.08.029
Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells
Abstract
Opioid-containing leukocytes can counteract inflammatory hyperalgesia. Under stress or after local injection of corticotropin releasing factor (CRF), opioid peptides are released from leukocytes, bind to opioid receptors on peripheral sensory neurons and mediate antinociception. Since polymorphonuclear cells (PMN) are the predominant opioid-containing leukocyte subpopulation in early inflammation, we hypothesized that PMN and their recruitment by chemokines are important for peripheral opioid-mediated antinociception at this stage. Rats were intraplantarly injected with complete Freund's adjuvant (CFA). Using flow cytometry, immunohistochemistry, and ELISA, leukocyte subpopulations, chemokine receptor (CXCR2) expression on opioid-containing leukocytes and the CXCR2 ligands keratinocyte-derived chemokine (KC), macrophage inflammatory protein-2 (MIP-2) and cytokine-induced neutrophil chemoattractant-2 (CINC-2) were quantified. Paw pressure threshold (PPT) was determined before and after intraplantar and subcutaneous injection of CRF with or without naloxone. PMN depletion was achieved by intravenous injection of an antiserum. Chemokines were blocked by intraplantar injection of anti-MIP-2 and/or anti-KC antiserum. We found that at 2 h post CFA (i) intraplantar but not subcutaneous injection of CRF produced dose-dependent and naloxone-reversible antinociception (P<0.05, ANOVA). (ii) Opioid-containing leukocytes in the paw and CRF-induced antinociception were reduced after PMN depletion (P<0.05, t-test). (iii) Opioid-containing leukocytes mostly expressed CXCR2. MIP-2 and KC, but not CINC-2 were detectable in inflamed but not in noninflamed tissue (P<0.05, ANOVA). (iv) Combined but not single blockade of MIP-2 and KC reduced the number of opioid-containing leukocytes and peripheral opioid-mediated antinociception (P<0.05, t-test; P>0.05, ANOVA). In summary, in early inflammation peripheral opioid-mediated antinociception is critically dependent on PMN and their recruitment by CXCR2 chemokines.
Similar articles
-
Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression.Pain. 2004 Mar;108(1-2):67-75. doi: 10.1016/j.pain.2003.12.008. Pain. 2004. PMID: 15109509
-
Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells.FASEB J. 2006 Dec;20(14):2627-9. doi: 10.1096/fj.06-6077fje. Epub 2006 Oct 23. FASEB J. 2006. PMID: 17060402
-
Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain.J Leukoc Biol. 2006 May;79(5):1022-32. doi: 10.1189/jlb.0805452. Epub 2006 Mar 7. J Leukoc Biol. 2006. PMID: 16522746
-
Macrophage inflammatory protein-2 as mediator of inflammation in acute liver injury.World J Gastroenterol. 2017 May 7;23(17):3043-3052. doi: 10.3748/wjg.v23.i17.3043. World J Gastroenterol. 2017. PMID: 28533661 Free PMC article. Review.
-
Leukocytes as mediators of pain and analgesia.Curr Rheumatol Rep. 2007 Dec;9(6):503-10. doi: 10.1007/s11926-007-0081-3. Curr Rheumatol Rep. 2007. PMID: 18177605 Review.
Cited by
-
Roles of Gr-1+ leukocytes in postincisional nociceptive sensitization and inflammation.Anesthesiology. 2012 Sep;117(3):602-12. doi: 10.1097/ALN.0b013e3182655f9f. Anesthesiology. 2012. PMID: 22820848 Free PMC article.
-
Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats.Front Mol Neurosci. 2017 Aug 3;10:242. doi: 10.3389/fnmol.2017.00242. eCollection 2017. Front Mol Neurosci. 2017. PMID: 28824373 Free PMC article.
-
Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis.Ann Rheum Dis. 2007 Jul;66(7):871-9. doi: 10.1136/ard.2006.067066. Epub 2007 Feb 26. Ann Rheum Dis. 2007. PMID: 17324971 Free PMC article.
-
Leukocyte-derived opioid peptides and inhibition of pain.J Neuroimmune Pharmacol. 2006 Mar;1(1):90-7. doi: 10.1007/s11481-005-9002-2. J Neuroimmune Pharmacol. 2006. PMID: 18040794 Review.
-
γδ T Cells Modulate Myeloid Cell Recruitment but Not Pain During Peripheral Inflammation.Front Immunol. 2019 Mar 18;10:473. doi: 10.3389/fimmu.2019.00473. eCollection 2019. Front Immunol. 2019. PMID: 30936874 Free PMC article.
References
-
- Amano H, Oishi K, Sonoda F, Senba M, Wada A, Nakagawa H, Nagatake T. Role of cytokine-induced neutrophil chemoattractant-2 (CINC-2) alpha in a rat model of chronic bronchopulmonary infections with Pseudomonas aeruginosa. Cytokine. 2000;12:1662-1668.
-
- Barnes DA, Tse J, Kaufhold M, Owen M, Hesselgesser J, Strieter R, Horuk R, Perez HD. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest. 1998;101:2910-2919.
-
- Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, Strieter RM. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest. 2002;110:1703-1716.
-
- Brack A, Rittner HL, Machelska H, Beschmann K, Sitte N, Schäfer M, Stein C. Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology. 2004;100:149-157.
-
- Brack A, Rittner HL, Machelska H, Shaqura M, Mousa SA, Labuz D, Zöllner C, Schäfer M, Stein C. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain. 2004;108:67-75.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical